Eastman Chemical (NYSE: EMN) reported Q3 EPS of $2.46, $0.02 worse than the analyst estimate of $2.48. Revenue for the quarter came in at $2.72 billion versus the consensus estimate of $2.61 billion.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.